Literature DB >> 10606209

Nonphysiological overexpression of low-density lipoprotein receptors causes pathological intracellular lipid accumulation and the formation of cholesterol and cholesteryl ester crystals in vitro.

J Heeren1, D S Steinwaerder, F Schnieders, G Cichon, M Strauss, U Beisiegel.   

Abstract

Recent therapeutic strategies for the treatment of familial hypercholesterolemia have been based on liver-directed gene transfer of a functional low-density lipoprotein (LDL) receptor cDNA under control of viral or strong housekeeping promoters. Strong viral promoters including cytomegalovirus, Rous sarcoma virus, and simian virus 40 promoters are commonly employed to reach significant physiological effects. These promoters mediate constitutive and nonphysiological overexpression in every transduced cell, while the endogenous LDL receptor expression is controlled by a complex feedback mechanism based on intracellular cholesterol concentration. To investigate intracellular consequences of persistent LDL receptor overexpression we constructed a recombinant adenovirus encoding the human LDL receptor under control of the Rous sarcoma virus promoter. The metabolic and morphological effects of LDL receptor expression were characterized by uptake experiments with human hepatoma cells using fluorescent and radiolabeled LDL. We observed that large amounts of LDL accumulate within LDL receptor transduced cells, which eventually lead to massive intracellular lipid deposition. Kinetic experiments with LDL-supplemented medium resulted in numerous crystal shaped structures in the cytosol of transduced cells as visualized by digital interference contrast optic within 60 min after LDL supplementation. Thin layer chromatography analyses of cellular lipids suggested these crystalline structures to be dependent on intracellular cholesterol and cholesterol ester levels. Mock-infected cells showed neither cholesterol lipid accumulation nor crystal formation. In conclusion, our data demonstrate that nonphysiological overexpression of the LDL receptor can cause massive lipid accumulation, which cannot be compensated by the hepatoma cell metabolism. This phenomenon may result in negative selection of LDL receptor overexpressing cells in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10606209     DOI: 10.1007/s001099900045

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  5 in total

1.  A common polymorphism in the LDL receptor gene has multiple effects on LDL receptor function.

Authors:  Feng Gao; Hansel E Ihn; Marisa W Medina; Ronald M Krauss
Journal:  Hum Mol Genet       Date:  2013-01-07       Impact factor: 6.150

2.  Long-term physiologically regulated expression of the low-density lipoprotein receptor in vivo using genomic DNA mini-gene constructs.

Authors:  Olivia C Hibbitt; Eileen McNeil; Michele Mp Lufino; Len Seymour; Keith Channon; Richard Wade-Martins
Journal:  Mol Ther       Date:  2009-10-27       Impact factor: 11.454

3.  LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives.

Authors:  Faisal A Al-Allaf; Charles Coutelle; Simon N Waddington; Anna L David; Richard Harbottle; Michael Themis
Journal:  Int Arch Med       Date:  2010-12-13

4.  An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency.

Authors:  Michele M P Lufino; Roberto Manservigi; Richard Wade-Martins
Journal:  Nucleic Acids Res       Date:  2007-08-02       Impact factor: 16.971

5.  Episomal Nonviral Gene Therapy Vectors Slow Progression of Atherosclerosis in a Model of Familial Hypercholesterolemia.

Authors:  Alastair G Kerr; Lawrence Cs Tam; Ashley B Hale; Milena Cioroch; Gillian Douglas; Keith M Channon; Richard Wade-Martins
Journal:  Mol Ther Nucleic Acids       Date:  2016-11-08       Impact factor: 10.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.